Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease 2025-10-13 18:00
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood 2025-10-13 18:00
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025 2025-10-13 16:03
Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies 2025-10-13 14:26
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14 2025-10-13 08:47
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10
Reach Surgical's OMNIBOT Performs First Urology Robotic Telesurgeries in Latin America 2025-10-13 08:00
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 2025-10-11 20:45
Health in Your Hands? Asia's Top Health Experts Say 'Yes' and Reveal How 2025-10-10 14:43
Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan 2025-10-10 14:00
IHH Healthcare launches Global Incubator to fuel game-changing innovation 2025-10-10 13:09
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept) 2025-10-10 06:56
POMDOCTOR LIMITED Announces Closing of Initial Public Offering 2025-10-10 04:05
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission 2025-10-09 20:50
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™ 2025-10-09 19:00
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87 2025-10-09 17:27
Herbalgy, the Pain Management Expert, Partners with Heroes in White to Champion a "Pain-Relieving Serenity" Lifestyle 2025-10-09 14:18
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology 2025-10-09 13:10
1 13 14 15 16 17 481